Winston Wong, PharmD, Editor-in-Chief

Editor's Page

Working Together: Novel Partnerships and Patient Perspectives

11/19/2018

The internet has made global communication part of daily life in the United States—a few clicks on a computer or a phrase typed into a search engine can bring almost any type of knowledge to the user’s fingertips....

The...

11/19/2018

Journal of Clinical Pathways

Editor's Page

Increasing Access to Innovative Therapies

10/15/2018

Winston Wong , PharmD;

Innovations in cancer therapy hold remarkable potential to transform treatment of the disease, but it is not enough to innovate new treatments if they are not easily accessible to patients. While the issue of access...

...

10/15/2018

Journal of Clinical Pathways

Editor's Page

Updating the Cancer Ecosystem: Access, Reimbursement, and Experience

09/13/2018

Winston Wong , PharmD;

The advancements made in health care, and oncology care specifically, have improved treatment and patient care tremendously, and have the potential to make an even greater impact as care delivery becomes more...

The...

09/13/2018

Journal of Clinical Pathways

Editor's Page

Balancing Costs and Patient Safety When Navigating New Regulations

08/22/2018

Winston Wong , PharmD;

As new and exciting advancements in cancer drugs and care are made, updated guidance and regulations must follow. Oncologists and other stakeholders must keep up with the latest rules and regulations in order to...

As new...

08/22/2018

Journal of Clinical Pathways

Viewpoint

CMS Sets CAR-T Reimbursement Levels—Where Should the Patient Be Treated?

08/22/2018

Winston Wong , PharmD;

The Centers for Medicare and Medicaid Services (CMS) just announced their reimbursement level for the new chimeric antigen receptor T-cell (CAR-T) products. While it is in line with their standard reimbursement...

The...

08/22/2018

Journal of Clinical Pathways

Editor's Page

Transparency and Communication Among Oncology Care Stakeholders

06/14/2018

Winston Wong , PharmD;

The ongoing journey toward value-based care has led to innovations in care delivery and reimbursement. Many new concepts and strategies have evolved from concept to reality. We now have gathered enough long-term data...

The...

06/14/2018

Journal of Clinical Pathways

Editor's Page

Implications of the Changing Landscape in Acute Myeloid Leukemia for Clinical Pathways

05/21/2018

Winston Wong , PharmD;

Acute myelogenous leukemia (AML) is a rapid progressing malignancy of the myeloid progenitor cells, characterized by an uncontrolled proliferation of primitive blast cells replacing normal bone marrow cells. It is...

Acute...

05/21/2018

Journal of Clinical Pathways

Editor's Page

Early Learnings From Innovators in the Pursuit of Value-Based Care

05/15/2018

Winston Wong , PharmD;

Making the transition from fee-for-service reimbursement to value-based models of care and payments will be slow and difficult. As the initial concepts behind value-based reimbursement and care delivery models...

Making...

05/15/2018

Journal of Clinical Pathways

Viewpoint

The CAR-T Breakthrough: More Than Just Another Treatment Option

04/17/2018

Winston Wong , PharmD;

The ability to rewire human immune systems to fight cancer is certainly an exciting prospect. With the first 2 chimeric antigen receptor T-cell (CAR-T) therapies approved and over 200 more in clinical trials,...

The...

04/17/2018

Journal of Clinical Pathways

Editor's Page

Working Together to Ensure Patient Access to Clinical Advancements

04/17/2018

Winston Wong , PharmD;

It is an exciting time in oncology care as innovative cellular and gene therapies come to market, with many more to come in the near future. While the promise of these therapies is certainly cause for enthusiasm,...

It is...

04/17/2018

Journal of Clinical Pathways